Lv1
38 积分 2024-09-02 加入
RANDOMIZED CONTROLLED STUDY OF INTRAVITREAL BEVACIZUMAB 0.16 MG INJECTED ONE DAY BEFORE SURGERY FOR PROLIFERATIVE DIABETIC RETINOPATHY
12小时前
待确认
Experience with intravitreal bevacizumab as a preoperative adjunct in 23-G vitrectomy for advanced proliferative diabetic retinopathy
13小时前
已完结
Intravitreal bevacizumab for surgical treatment of severe proliferative diabetic retinopathy
13小时前
已完结
INTRAVITREAL CONBERCEPT (KH902) FOR SURGICAL TREATMENT OF SEVERE PROLIFERATIVE DIABETIC RETINOPATHY
13小时前
已完结
Perioperative anti-VEGF therapy for proliferative diabetic retinopathy: a network meta-analysis of RCTs
1个月前
已完结
Ranibizumab 0.5 mg in Asian patients with visual impairment due to macular edema secondary to central retinal vein occlusion: results from the 12-month CAMELLIA study
1个月前
已关闭
Intravitreal Aflibercept Injection in Patients with Myopic Choroidal Neovascularization
1个月前
已完结
RADIANCE: A Randomized Controlled Study of Ranibizumab in Patients with Choroidal Neovascularization Secondary to Pathologic Myopia
1个月前
已完结
Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy
2个月前
已完结
Real-world effect of vitrectomy combined with intravitreal conbercept for treatment of vitreous haemorrhage in proliferative diabetic retinopathy (QILIN I): a prospective cohort study
2个月前
已完结
皖公网安备34019202002308
